Funds holding GRI BIO INC
ISIN US3622AW5029 · United States
- Fund holders
- 2
- Of which ETFs
- 0 2 other funds
- Value held
- 20K $
- Share of capital
- 0.4 % of 2.2M shares on Aug 13, 2026
2 tracked funds declare this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 7,765 | 19.8K $ | 0.36 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 97 | 247.4 $ | 0.00 % | as of Feb 28, 2026 ↗ |
Institutional managers
6 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 18,438 | 42.2K $ | as of Mar 31, 2026 |
| UBS Group AG | 8,722 | 20K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,060 | 2.4K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 7 | 16 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 4 | 9 $ | as of Mar 31, 2026 |
| DANSKE BANK A/S | 2 | 5 $ | as of Mar 31, 2026 |
Declared shareholders of GRI BIO INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Mitchell P. Kopin and 2 others | 5.90 % | 90,475 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding GRI BIO INC". https://titelia.com/en/stocks/gri-bio-inc-US3622AW5029